The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2018-08-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether exercise can be prolonged in COPD can by
the inhaled bronchodilator Stiolto Respimat. The study will identify whether any endurance
benefit is due to reduction in fatigue that originates within the skeletal muscles and/or
from effects on neural activation of the skeletal muscles.
Phase:
Phase 4
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center